Skip to main content

Table 3 Cardiovascular disease risk factor and lifestyle data

From: Levels of S100B are raised in female patients with schizophrenia

CVD Risk factors

Patient group

Control group

Significance

Smoking status (+)

58/95 (61%)

8/27 (30%)

~2 fold increase

Diabetes mellitus (+)

6/95 (6%)

1/27 (0.04%)

>100 fold increase

Body Mass Index (BMI)

32.45 ± 0.62

27.53 ± 0.86

0.002***

Hypertension treatment

24/95 (25%)

6/27 (22%)

no change

Systolic blood pressure

123 ± 1.5

122 ± 0.16

0.5675

Total cholesterol

5.08 ± 0.13

5.11 ± 0.16

0.9117

Framingham (%)

7.01 ± 0.62

5.31 ± 0.89

0.1797

  1. Cardiovascular disease risk factors data and Framingham-10-year (%) risk of cardiovascular disease incident of patients treated with clozapine (n = 97) and healthy control subjects (n = 27). Data expressed as mean ± SEM. Statistical analysis was performed using Student’s unpaired T test (two-tailed). The significance levels (or alpha levels) were set at p < 0.001***.